 |
Axela provides protein detection, characterization and monitoring products used in life science, health and clinical research. Our proprietary Diffractive Optics Technology (dot™), is based on research techniques initially developed at the University of Toronto and is a novel, patented combination of two robust, well-understood technologies: grating-based light diffraction and immobilized capture surfaces. This unique combination produces a simple, highly sensitive, cost-effective platform for measuring protein levels and characterizing their interactions in real-time without labels. This capability makes the dotLab™ System the only protein-characterization platform that can be used at each stage of the assay development process, removing many of the obstacles associated with traditional end-point multiplex analysis. It allows researchers to rapidly move biomarker discoveries through the reagent qualification and assay development process into routine use.
Axela's corporate headquarters are located in Toronto, ON Canada. We have representatives throughout the US and Canada and are currently expanding into Europe and Asia.
|
